ISL1 and breast cancer: Interestingly, CA10 was presented as a novel TS BC marker identified by the triple immunofluorescent staining of CA10+/NETO1+/RBPMS− (OFF_BCs) and CA10+/ISL1+/RBPMS− (ON_BCs) in the INL at the different age stages (Fig. 3E).